Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 423494103 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
RA Capital Management, L.P.
13G
|
16.6% |
5/11/2026
Event 5/4/2026
|
|
| RA Capital Management, L.P. | 16.6% | ||
| Peter Kolchinsky | 16.6% | ||
| Rajeev Shah | 16.6% | ||
| RA Capital Healthcare Fund, L.P. | 13.6% | ||
|
AI Den-Mab LLC
13D
|
10.4% |
5/11/2026
Event 5/4/2026
|
|
| AI Den-Mab LLC | 10.4% | ||
| Access Industries Holdings LLC | 10.4% | ||
| AI Biotechnology LLC | 10.4% | ||
| Access Industries Management LLC | 10.4% | ||
| Len Blavatnik | 10.4% | ||
| Novo Holdings A/S 13G | 9.0% |
8/14/2026
Event 6/30/2026
|
|
|
Deep Track Capital, LP
13G
|
8.2% |
5/8/2026
Event 5/1/2026
|
|
| Deep Track Capital, LP | 8.2% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.8% | ||
| David Kroin | 8.2% | ||
| Deep Track Special Opportunities Fund, LP. | 1.4% | ||
|
FMR LLC
13G
|
7.9% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 7.9% | ||
| Abigail P. Johnson | 7.9% | ||
| Capital International Investors 13G | 7.7% |
8/12/2026
Event 6/30/2026
|
|
|
Avoro Capital Advisors LLC
13G
|
7.1% |
8/14/2026
Event 6/30/2026
|
|
| Avoro Capital Advisors LLC | 4.1% | ||
| Avoro Ventures LLC | 2.9% | ||
| Behzad Aghazadeh | 7.1% | ||
|
Sofinnova Crossover II S.L.P.
13G
|
5.4% |
8/5/2026
Event 6/30/2026
|
|
| Sofinnova Crossover II SLP | 5.4% | ||
| Sofinnova Partners SAS, a French corporation | 5.4% | ||
| Antoine Papiernik | 5.4% | ||
| Cedric Moreau | 5.4% | ||
| Kinam Hong | 5.4% | ||
| Joseph Anderson | 5.4% | ||
| David Evans | 5.4% | ||
|
Invus Global Management, LLC
13G
|
5.1% |
8/7/2026
Event 8/3/2026
|
|
| Invus Public Equities, L.P. | 4.9% | ||
| Invus Public Equities Advisors, LLC | 4.9% | ||
| Invus Global Management, LLC | 4.9% | ||
| Siren, L.L.C. | 4.9% | ||
| Avicenna Life Sci Master Fund LP | 0.2% | ||
| Avicenna Life Sci Master GP LLC | 0.2% | ||
| Ulys, L.L.C. | 0.2% | ||
| Raymond Debbane | 5.1% |